In this episode, we sat down with Jamil Beg, Partner at 5AM Ventures, a leading venture capital firm focused on building next-generation life science companies. We discuss Jamil's career journey, the challenges in scaling early-stage biotech companies, the current life science investing landscape, and much more.

Founded in 2002, 5AM has invested in 100 companies and raised over $2.0 billion since inception. Through its 4:59 Initiative, 5AM discovers, incubates, and funds breakthrough science by partnering with academics and entrepreneurs to establish proof-of-concept data that will enable a Series A financing. 5AM has offices in Boston and San Francisco.